Related Experiment Video
Updated: Dec 25, 2025

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples
Published on: May 19, 2020
Predictors of Tuberculosis outcomes amongst drug sensitive patients in Boteti sub-district, Botswana, 2015-2017
Gabalape Arnold Sejie1, Ozayr Mahomed1
1Discipline of Public Health Medicine, University of KwaZulu, Natal, South Africa.
Introduction:
The. Boteti sub-district in Botswana has a high TB notification rate of 356 per 100 000 population in 2013, a Treatment completion rate of 55%, 13% cure rate, and 4% defaulter rate in 2014. The high TB notification and defaulter rates with lower cure and treatment success rates in this sub-district relative to the country, are indicative of certain determinants that may be hampering TB control. The aim of this study was to determine the factors associated drug sensitive TB treatment outcomes.
Methods:
A retrospective cohort study was conducted amongst all the new-smear positive adult pulmonary TB patients who registered and/or completed the treatment period at the six selected health-care centres in Boteti sub-district, between 1 January 2015 and 31 January 2017. An interviewer-administered questionnaire in the patient's language of choice- Setswana or English was utilised for data collection. Adjusted risk ratios (ARR) and their respective 95% confidence intervals (95% CI) were used for expressing associations.
Results:
Fifty-eight (56.9%) patients were successfully cured compared to 44 (43.1%) who successfully completed treatment. Patients that attended the clinics by foot (ARR 3.38) (P < 0.05), females (ARR: 1.25) and HIV negative patients (ARR: 1.20) were more likely to achieve TB cure. Patients that attended the facility with a vehicle were 2.12 (P < 0.000), a primary school and above education (ARR: 1.59), travelled less than 5 km (ARR: 1.05) and less than 38 years of age (ARR:1.02) were more likely to complete TB treatment.
Conclusion:
A comprehensive health promotion approach based on the Ottawa charter principles to should be developed and implemented.
More Related Videos
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
10:29A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
Published on: March 24, 2017
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Therapeutic Drug Monitoring: Affecting Factors